ArticleWorld journal of microbiology & biotechnology2025
Laminaria Japonica hydrolysate as a novel biostimulant for enhancing DHA accumulation in Aurantiochytrium limacinum.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sustainable microalgae-based Docosahexaenoic Acid-Silver nanoparticles for biomedical applications.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Aurantiochytrium limacinum is recognized as an ideal candidate to produce docosahexaenoic acid (DHA). However, elevating the biomass and lipid yield on a large scale is still a challenge. In this study, a simple and feasible strategy for enhancing DHA accumulation based on Laminaria japonica hydrolysate (LPH) addition has been developed. The addition of 40 mL/L LPH enhanced the accumulation of biomass and lipid of A. limacinum by 31.48% and 49.48%, respectively. Meanwhile, the DHA production was increased by 40.78%. By investigating the effects on DHA and biomass accumulation hormones in LPH, gibberellin 3, abscisic acid, and salicylic acid were characterized as the key factor. With the addition of LPH, the upregulated genes were enriched in pathways including fatty acid biosynthesis, metabolism, and the tricarboxylic acid cycle. In particular, key genes involved in fatty acid synthesis, such as ACC1 and FAS2, were significantly upregulated. In this study, LPH was identified as a novel additive with practical application value due to its readily available and low-cost raw ingredients.
Indexed as
Identifiers
40736607What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.